STOCK TITAN

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on gene-based medicines for serious diseases, announced its participation in upcoming investor conferences. Their senior management team will present at the Jefferies Healthcare Conference on June 5, 2024, at 10:00 a.m. ET, and the Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024, at 9:20 a.m. ET. Live webcasts of these presentations will be accessible on the Investor section of the company's website and archived for 14 days post-event.

Positive
  • CRISPR Therapeutics' participation in high-profile investor conferences could increase investor interest and visibility.
  • The company is presenting at two major healthcare conferences, indicating active investor engagement.
  • Availability of live webcasts and archived replays enhances transparency and accessibility for potential investors.
Negative
  • The press release lacks concrete updates on financial or clinical data, which might be anticipated by investors.
  • No new product or business development announcements were included, which may be seen as a missed opportunity.

ZUG, Switzerland and BOSTON, May 29, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in the following investor conferences in June.

Jefferies Healthcare Conference
Date: Wednesday, June 5, 2024
Time: 10:00 a.m. ET

Goldman Sach’s 45th Annual Global Healthcare Conference
Date: Tuesday, June 11, 2024
Time: 9:20 a.m. ET

A live webcast will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the webcasts will be archived on the Company's website for 14 days following the presentation.

About CRISPR Therapeutics
Since its inception over a decade ago, CRISPR Therapeutics has transformed from a research-stage company advancing programs in the field of gene editing, to a company that recently celebrated the historic approval of the first-ever CRISPR-based therapy and has a diverse portfolio of product candidates across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, cardiovascular, autoimmune, and rare diseases. CRISPR Therapeutics advanced the first-ever CRISPR/Cas9 gene-edited therapy into the clinic in 2018 to investigate the treatment of sickle cell disease or transfusion-dependent beta thalassemia, and beginning in late 2023, CASGEVY™ (exagamglogene autotemcel) was approved in some countries to treat eligible patients with either of those conditions. The Nobel Prize-winning CRISPR science has revolutionized biomedical research and represents a powerful, clinically validated approach with the potential to create a new class of potentially transformative medicines. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic partnerships with leading companies including Bayer and Vertex Pharmaceuticals. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Boston, Massachusetts and San Francisco, California, and business offices in London, United Kingdom. To learn more, visit www.crisprtx.com.

Investor Contact:
Susan Kim
+1-617-307-7503
susan.kim@crisprtx.com

Media Contact:
Rachel Eides
+1-617-315-4493
rachel.eides@crisprtx.com


FAQ

When will CRISPR Therapeutics present at the Jefferies Healthcare Conference in 2024?

CRISPR Therapeutics will present at the Jefferies Healthcare Conference on June 5, 2024, at 10:00 a.m. ET.

What time is CRISPR Therapeutics' presentation at the Goldman Sachs 45th Annual Global Healthcare Conference?

CRISPR Therapeutics will present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024, at 9:20 a.m. ET.

Where can I watch the live webcasts of CRISPR Therapeutics' presentations?

Live webcasts of CRISPR Therapeutics' presentations will be available on the Investor section of the company's website.

How long will the webcasts of CRISPR Therapeutics' presentations be available online?

The webcasts will be archived and available for 14 days following the presentations.

CRISPR Therapeutics AG

NASDAQ:CRSP

CRSP Rankings

CRSP Latest News

CRSP Stock Data

4.37B
85.17M
1.74%
80.35%
20.66%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
ZUG